Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 33 Researches
7.4
USERS' SCORE
Moderately Good
Based on 46 Reviews
7.8
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Calories
10
Total Fat
1 g
1%
Saturated Fat
0 g
0%
Trans Fat
0 g
**
Polyunsaturated Fat
0.5 g
**
Monounsaturated Fat
0 g
**
Cholesterol
10 mg
3%
Omega-3 Fish Oil
1000 mg
**
EPA (Eicosapentaenoic Acid)
180 mg
**
DHA (Docosahexaenoic Acid)
120 mg
**
Top Medical Research Studies
9
We investigated the link between plasma omega-3 levels and the risk of heart failure (HF) in a large UK cohort study. Our analysis revealed that higher omega-3 levels were associated with a 21% lower chance of developing HF over nearly 14 years.
For individuals already diagnosed with HF, elevated omega-3 levels corresponded to about a 50% reduction in the risk of overall and cardiovascular mortality. These results suggest that boosting omega-3 intake through diet or supplements may help prevent HF and increase longevity for those already facing heart challenges.
For individuals already diagnosed with HF, elevated omega-3 levels corresponded to about a 50% reduction in the risk of overall and cardiovascular mortality. These results suggest that boosting omega-3 intake through diet or supplements may help prevent HF and increase longevity for those already facing heart challenges.
Read More
9
Omega-3 reduces cardiovascular risk
We observed the effects of icosapent ethyl on heart health in a significant clinical trial involving statin-treated patients at high risk for cardiovascular events. This post hoc analysis revealed that icosapent ethyl reduced major cardiovascular issues, regardless of whether patients had low-density lipoprotein cholesterol (LDL-C) levels below or above 55 mg/dL.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
Read More
8
We explored the impact of eicosapentaenoic acid (EPA) on heart health by studying mice on a high-fat diet. Those supplemented with EPA showed a significant reduction in atrial fibrillation compared to those without. While 100% of the high-fat diet mice developed atrial fibrillation, only 50% of those receiving EPA did, and their episodes were shorter.
Our findings suggest that including EPA in the diet can help improve heart function and reduce irregular heart rhythms linked to high-fat diets.
Our findings suggest that including EPA in the diet can help improve heart function and reduce irregular heart rhythms linked to high-fat diets.
Read More
Most Useful Reviews
9
Cardiovascular remedy
33 people found this helpful
This "Mega" omega fish oil is superb! It helps reduce cholesterol concentrations, acts as a preventive measure against cardiovascular disease, and has shown potential in cancer prevention. Omega 3 aids in skin conditions, allergies, and arthritis, often providing relief in just days. It's crucial for brain function and normal embryo development. I take 3-4 capsules daily with meals.
Read More
9
Essential nutrient
4 people found this helpful
This is my favourite omega. The triglyceride form enhances absorption, aiding the cardiovascular system, brain function, and joint health. It’s simpler to take capsules than consume fish regularly. I integrate it into my daily routine, believing it’s essential for health.
Read More
9
Lowers heart risks
1 people found this helpful
Omega-3 lowers blood pressure and triglycerides, reducing blockage, atherosclerosis, and risks of heart attack or stroke. It also decreases the likelihood of sudden death from heart disease.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 33 Researches
7.4
- All Researches
9
Omega-3 reduces cardiovascular risk
We observed the effects of icosapent ethyl on heart health in a significant clinical trial involving statin-treated patients at high risk for cardiovascular events. This post hoc analysis revealed that icosapent ethyl reduced major cardiovascular issues, regardless of whether patients had low-density lipoprotein cholesterol (LDL-C) levels below or above 55 mg/dL.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
Read More
9
We assessed how omega-3 fatty acids (PUFAs) can support heart failure management through a thorough network meta-analysis of 14 studies with nearly 9,100 participants.
Our findings revealed that high doses (2,000-4,000 mg/day) taken for at least one year significantly improved heart function, particularly the left ventricular ejection fraction and peak oxygen consumption.
However, lower doses and shorter durations were not effective, and we found no major differences in safety measures like dropout rates or overall mortality between those taking omega-3 and those who were not.
Our findings revealed that high doses (2,000-4,000 mg/day) taken for at least one year significantly improved heart function, particularly the left ventricular ejection fraction and peak oxygen consumption.
However, lower doses and shorter durations were not effective, and we found no major differences in safety measures like dropout rates or overall mortality between those taking omega-3 and those who were not.
Read More
9
We investigated the link between plasma omega-3 levels and the risk of heart failure (HF) in a large UK cohort study. Our analysis revealed that higher omega-3 levels were associated with a 21% lower chance of developing HF over nearly 14 years.
For individuals already diagnosed with HF, elevated omega-3 levels corresponded to about a 50% reduction in the risk of overall and cardiovascular mortality. These results suggest that boosting omega-3 intake through diet or supplements may help prevent HF and increase longevity for those already facing heart challenges.
For individuals already diagnosed with HF, elevated omega-3 levels corresponded to about a 50% reduction in the risk of overall and cardiovascular mortality. These results suggest that boosting omega-3 intake through diet or supplements may help prevent HF and increase longevity for those already facing heart challenges.
Read More
9
We delved into how Antarctic krill oil, rich in eicosapentaenoic acid (EPA), can influence cardiovascular health, specifically in the context of obesity. Our focus centered on its effects in mice fed a high-fat diet, which typically leads to increased cholesterol levels and oxidative stress—conditions that can heighten cardiovascular disease risk.
Through our research methods, including molecular docking and analysis of liver histology, we discovered that Antarctic krill oil appears to play a beneficial role in combating these adverse effects. We observed that the oil reduced oxidative stress and fat accumulation in these obese mice. This was associated with improved metabolic parameters that contribute to heart health, primarily through its action on molecules involved in cholesterol metabolism.
Notably, we found that krill oil helped lower the levels of harmful low-density lipoprotein cholesterol and activated pathways that support good cholesterol management in the body. These findings suggest that incorporating Antarctic krill oil, with its high EPA content, might be a promising strategy for addressing obesity-related cardiovascular issues.
Overall, our study points to the potential of eicosapentaenoic acid from krill oil as a natural approach to improving heart health, particularly for those struggling with obesity and its challenges.
Through our research methods, including molecular docking and analysis of liver histology, we discovered that Antarctic krill oil appears to play a beneficial role in combating these adverse effects. We observed that the oil reduced oxidative stress and fat accumulation in these obese mice. This was associated with improved metabolic parameters that contribute to heart health, primarily through its action on molecules involved in cholesterol metabolism.
Notably, we found that krill oil helped lower the levels of harmful low-density lipoprotein cholesterol and activated pathways that support good cholesterol management in the body. These findings suggest that incorporating Antarctic krill oil, with its high EPA content, might be a promising strategy for addressing obesity-related cardiovascular issues.
Overall, our study points to the potential of eicosapentaenoic acid from krill oil as a natural approach to improving heart health, particularly for those struggling with obesity and its challenges.
Read More
8
This study examined how different fatty acids affect heart health, particularly focusing on long-chain acylcarnitines. We found that saturated and monounsaturated acylcarnitines, especially one type called trans-elaidoylcarnitine, can significantly harm heart function and cell viability.
On the other hand, omega-3 derived acylcarnitines like eicosapentaenoylcarnitine and docosahexaenoylcarnitine showed minimal negative effects. In fact, they did not impair heart function or cell viability, suggesting that omega-3 fish oil might be a safer option for people with heart issues compared to other fatty acid sources.
On the other hand, omega-3 derived acylcarnitines like eicosapentaenoylcarnitine and docosahexaenoylcarnitine showed minimal negative effects. In fact, they did not impair heart function or cell viability, suggesting that omega-3 fish oil might be a safer option for people with heart issues compared to other fatty acid sources.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 46 Reviews
7.8
- All Reviews
- Positive Reviews
- Negative Reviews
9
Cardiovascular remedy
33 people found this helpful
This "Mega" omega fish oil is superb! It helps reduce cholesterol concentrations, acts as a preventive measure against cardiovascular disease, and has shown potential in cancer prevention. Omega 3 aids in skin conditions, allergies, and arthritis, often providing relief in just days. It's crucial for brain function and normal embryo development. I take 3-4 capsules daily with meals.
Read More
9
Essential nutrient
4 people found this helpful
This is my favourite omega. The triglyceride form enhances absorption, aiding the cardiovascular system, brain function, and joint health. It’s simpler to take capsules than consume fish regularly. I integrate it into my daily routine, believing it’s essential for health.
Read More
9
Lowers heart risks
1 people found this helpful
Omega-3 lowers blood pressure and triglycerides, reducing blockage, atherosclerosis, and risks of heart attack or stroke. It also decreases the likelihood of sudden death from heart disease.
Read More
9
Winter health benefits
1 people found this helpful
Super fish oil! I began using this product for my family last summer. The results were quick; winter passed without illness, and my grandmother, who turns 80 this year, looks and feels amazing. If you weigh more, like me (103 kg – athlete), take two capsules in the morning and evening!
Read More
9
Cardiovascular system support
This product offers excellent value for money. Omega-3 is essential for the nervous and cardiovascular systems, enhancing heart health and preventing gastric issues. I recommend it to all my friends; the price is effective for such benefits.
Read More
Frequently Asked Questions
9
Winter health benefits
1 people found this helpful
Super fish oil! I began using this product for my family last summer. The results were quick; winter passed without illness, and my grandmother, who turns 80 this year, looks and feels amazing. If you weigh more, like me (103 kg – athlete), take two capsules in the morning and evening!
9
Heart disease risk reduction
42 people found this helpful
I noticed reduced blood pressure and a lower risk of cardiovascular disease. I'm particularly grateful for the decrease in heart attack risks. Please give me a like! May peace be upon you and your family.
9
Cardiovascular remedy
33 people found this helpful
This "Mega" omega fish oil is superb! It helps reduce cholesterol concentrations, acts as a preventive measure against cardiovascular disease, and has shown potential in cancer prevention. Omega 3 aids in skin conditions, allergies, and arthritis, often providing relief in just days. It's crucial for brain function and normal embryo development. I take 3-4 capsules daily with meals.
7.5
Regulates blood lipids
1 people found this helpful
This fish oil is cost-effective and has worked well for my mother, who has normal blood lipids thanks to its consumption. It's beneficial for those with cardiovascular disease, helping to manage blood lipids and reduce the risk of coronary heart disease.
9
Lowers heart risks
1 people found this helpful
Omega-3 lowers blood pressure and triglycerides, reducing blockage, atherosclerosis, and risks of heart attack or stroke. It also decreases the likelihood of sudden death from heart disease.
7.5
Boosts cardiovascular health
2 people found this helpful
The positive effects of Natrol Fish Oil are evident: my skin peeling is gone, and I feel more energetic throughout the day. I hope it also benefits my cardiovascular system, as the packaging claims.
9
Supports heart health
3 people found this helpful
My favourite omega-3! It effectively supports my cardiovascular system, and my hand dry skin has improved significantly.
9
Essential nutrient
4 people found this helpful
This is my favourite omega. The triglyceride form enhances absorption, aiding the cardiovascular system, brain function, and joint health. It’s simpler to take capsules than consume fish regularly. I integrate it into my daily routine, believing it’s essential for health.
9
Omega-3 benefits
I take this for prevention. The importance of Omega-3 cannot be overstated; it helps to cleanse blood vessels of "bad" cholesterol, reducing the risk of cardiovascular disease. It improves blood viscosity, normalises blood pressure, and raises "good" cholesterol levels. Omega-3 also boosts serotonin production, enhancing mood and immunity. As our bodies cannot produce Omega-3, supplements are vital. I take two capsules at lunch, which curb my hunger. I suggest consulting a doctor for treatment dosages, and remember potential contraindications.
7.5
Transparent dosage
5 people found this helpful
Natrol offers excellent fish oil with a clear dosage of 1000mg per capsule. It's convenient to take, and I appreciate its compatibility with other supplements. I recommend checking dosage information when choosing omega products for cardiovascular health.
9
Reduces cardiovascular risk
3 people found this helpful
This is one of the best products I’ve used, containing high-quality ingredients that evidently reduce the risk of cardiovascular disease and cleanse the body of toxins. I've heard positive results since I began using this brand. Suitable for all ages, it offers multiple benefits.
8
We aimed to explore the use of eicosapentaenoic acid (EPA), a type of marine omega-3 fatty acid, in lowering cardiovascular risk among patients recovering from acute coronary syndromes (ACS). In our study, we analyzed data from a Swiss group of 2,643 patients who were hospitalized for ACS.
One year after their first heart event, we found that 32% of these patients were eligible for EPA supplementation, particularly those with elevated triglyceride levels. Notably, eligibility was higher among younger individuals, smokers, diabetics, hypertensive patients, and those who were obese.
We also looked into potential ways to enhance this eligibility through additional lipid-lowering therapies, such as statins and ezetimibe. However, despite these adjustments in treatment strategies, we observed only a slight reduction in the percentage of patients who met the criteria for EPA supplementation.
This finding suggests that there's a significant opportunity to reduce cardiovascular risks in those who qualify for EPA, especially among patients with hypertriglyceridemia. It becomes clear that integrating omega-3 fatty acids into treatment plans could be beneficial for many patients in this high-risk group.
One year after their first heart event, we found that 32% of these patients were eligible for EPA supplementation, particularly those with elevated triglyceride levels. Notably, eligibility was higher among younger individuals, smokers, diabetics, hypertensive patients, and those who were obese.
We also looked into potential ways to enhance this eligibility through additional lipid-lowering therapies, such as statins and ezetimibe. However, despite these adjustments in treatment strategies, we observed only a slight reduction in the percentage of patients who met the criteria for EPA supplementation.
This finding suggests that there's a significant opportunity to reduce cardiovascular risks in those who qualify for EPA, especially among patients with hypertriglyceridemia. It becomes clear that integrating omega-3 fatty acids into treatment plans could be beneficial for many patients in this high-risk group.
9
Omega-3 reduces cardiovascular risk
We observed the effects of icosapent ethyl on heart health in a significant clinical trial involving statin-treated patients at high risk for cardiovascular events. This post hoc analysis revealed that icosapent ethyl reduced major cardiovascular issues, regardless of whether patients had low-density lipoprotein cholesterol (LDL-C) levels below or above 55 mg/dL.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
Notably, those with optimal LDL-C control still benefited from the treatment, showing that this fish oil derivative can be effective in managing heart risks for many patients.
9
We assessed how omega-3 fatty acids (PUFAs) can support heart failure management through a thorough network meta-analysis of 14 studies with nearly 9,100 participants.
Our findings revealed that high doses (2,000-4,000 mg/day) taken for at least one year significantly improved heart function, particularly the left ventricular ejection fraction and peak oxygen consumption.
However, lower doses and shorter durations were not effective, and we found no major differences in safety measures like dropout rates or overall mortality between those taking omega-3 and those who were not.
Our findings revealed that high doses (2,000-4,000 mg/day) taken for at least one year significantly improved heart function, particularly the left ventricular ejection fraction and peak oxygen consumption.
However, lower doses and shorter durations were not effective, and we found no major differences in safety measures like dropout rates or overall mortality between those taking omega-3 and those who were not.
8
We explored the potential connection between eicosapentaenoic acid (EPA), which is an omega-3 fatty acid, and its role in reducing inflammation related to cardiovascular disease (CVD) in older adults. In our study, we measured the plasma levels of various omega-3 fatty acids and their specialized pro-resolving lipid mediators (SPMs) in a group of 21 older participants who exhibited low-grade chronic inflammation.
The findings were intriguing. We observed that higher levels of docosahexaenoic acid (DHA) were linked to lower concentrations of several inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Additionally, certain SPMs derived from EPA and DHA were also associated with reductions in inflammation levels, suggesting that these omega-3-derived substances might support the body's natural ability to resolve inflammation.
However, while the association between omega-3 fatty acids and inflammation was apparent, our study did not isolate the effects of EPA alone. This means we cannot definitively conclude the unique impact of eicosapentaenoic acid on cardiovascular health.
Overall, this research sheds light on how dietary intake of omega-3 fatty acids, particularly from sources rich in DHA and EPA, may benefit inflammation regulation—an important aspect of cardiovascular well-being.
The findings were intriguing. We observed that higher levels of docosahexaenoic acid (DHA) were linked to lower concentrations of several inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Additionally, certain SPMs derived from EPA and DHA were also associated with reductions in inflammation levels, suggesting that these omega-3-derived substances might support the body's natural ability to resolve inflammation.
However, while the association between omega-3 fatty acids and inflammation was apparent, our study did not isolate the effects of EPA alone. This means we cannot definitively conclude the unique impact of eicosapentaenoic acid on cardiovascular health.
Overall, this research sheds light on how dietary intake of omega-3 fatty acids, particularly from sources rich in DHA and EPA, may benefit inflammation regulation—an important aspect of cardiovascular well-being.
8
We examined the effects of dietary omega-3 polyunsaturated fatty acids (Dω-3 PUFAs) on cardiovascular diseases (CVDs) through recent clinical trials and food fortification trends.
Evidence suggests that these beneficial fatty acids can lower heart disease risk, improve blood pressure, and enhance lipid profiles.
While advancements in fortifying foods with Dω-3 PUFAs show promise, there's still a need for more research to maximize their health benefits and ensure better protection against CVDs.
Evidence suggests that these beneficial fatty acids can lower heart disease risk, improve blood pressure, and enhance lipid profiles.
While advancements in fortifying foods with Dω-3 PUFAs show promise, there's still a need for more research to maximize their health benefits and ensure better protection against CVDs.
4
Genetics influence omega-3 effectiveness
We aimed to evaluate how genetic factors influence the effectiveness of fish oil supplementation on fatty acid profiles in healthy individuals.
In this study, 86 adults participated in a 4-week fish oil program, and their lipid profiles were assessed before and after the supplementation.
We found that genetic variations, specifically in the FADS1 and ELOVL2 genes, might affect how well the body utilizes omega-3 fatty acids.
This highlights the potential for personalized nutrition to enhance cardiovascular health.
In this study, 86 adults participated in a 4-week fish oil program, and their lipid profiles were assessed before and after the supplementation.
We found that genetic variations, specifically in the FADS1 and ELOVL2 genes, might affect how well the body utilizes omega-3 fatty acids.
This highlights the potential for personalized nutrition to enhance cardiovascular health.
References
- Liepinsh E, Gukalova B, Krims-Davis K, Kuka J, Leduskrasta A, et al. EPA and DHA acylcarnitines are less cardiotoxic than are saturated and monounsaturated long-chain acylcarnitines. Biofactors. 2025;51:e70014. doi:10.1002/biof.70014
- Medoro A, Graziano F, Cardinale G, Voccola S, Zotti T, et al. The influence of FADS1 and ELOVL2 genetic polymorphisms on polyunsaturated fatty acid composition in response to fish oil supplementation. Lipids Health Dis. 2025;24:102. doi:10.1186/s12944-025-02513-w
- Horii K, Ono K, Sumi T, Higashihara M, Zaima N, et al. Eicosapentaenoic acid prevents atrial electrocardiographic impairments and atrial fibrillation in high fat diet mice. J Physiol Sci. 2025;75:100014. doi:10.1016/j.jphyss.2025.100014
- Dawczynski C, Drobner T, Weidauer T, Schlattmann P, Kiehntopf M, et al. Reduction of cardiovascular risk factors by the diet - Evaluation of the MoKaRi concept by a parallel-designed randomized study. Lipids Health Dis. 2025;24:88. doi:10.1186/s12944-025-02500-1
- Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, et al. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025;14:e038656. doi:10.1161/JAHA.124.038656
- Mao Q, Tian X, Wang X, Xu H, Zhang Y, et al. Global burden of cardiovascular diseases attributable to diet low in seafood omega-3 fatty acids from 1990~2021 and forecasting the future trends: A population-based study. PLoS One. 2025;20:e0316767. doi:10.1371/journal.pone.0316767
- Tseng PT, Zeng BY, Hsu CW, Liang CS, Stubbs B, et al. The Optimal Dosage and Duration of ω-3 PUFA Supplementation in Heart Failure Management: Evidence from a Network Meta-Analysis. Adv Nutr. 2025;16:100366. doi:10.1016/j.advnut.2025.100366
- Hemmati R, Bahrami Zanjanbar D, Shishesaz MI, Soleimani A, Yari T. The impact of Omega-3 supplementation on arrhythmia reduction in acute coronary syndrome patients: a randomized clinical trial. J Complement Integr Med. 2025;22:173. doi:10.1515/jcim-2024-0427
- Wang Y, Wu G, Wang Y, Rehman A, Yu L, et al. Recent developments, challenges, and prospects of dietary omega-3 PUFA-fortified foods: Focusing on their effects on cardiovascular diseases. Food Chem. 2025;470:142498. doi:10.1016/j.foodchem.2024.142498
- Dong S, Wang Y, Bian J, Chen H, Dong J, et al. The effect of omega-3 Polyunsaturated Fatty Acid (PUFA) prescription preparations on the prevention of clinical cardiovascular disease: a meta-analysis of RCTs. Nutr J. 2024;23:157. doi:10.1186/s12937-024-01051-y
- Jawad MA, O'Keefe JH, Tintle N, O'Keefe EL, Franco WG, et al. Association of Plasma Omega-3 Levels With Incident Heart Failure and Related Mortalities. Mayo Clin Proc. 2024;99:1895. doi:10.1016/j.mayocp.2024.08.007
- Brosolo G, Da Porto A, Marcante S, Capilupi F, Bertin N, et al. The role for ω-3 polyunsaturated and short chain fatty acids in hypertension: An updated view on the interaction with gut microbiota. Eur J Pharmacol. 2024;985:177107. doi:10.1016/j.ejphar.2024.177107
- Lee YQ, Tan KH, Chong MF. Biomarkers of PUFA and cardiovascular risk factors and events in healthy Asian populations: a systematic review. Br J Nutr. 2024;132:1474. doi:10.1017/S0007114524002708
- Li J, Nan W, Huang X, Meng H, Wang S, et al. Eicosapentaenoic acid induces macrophage Mox polarization to prevent diabetic cardiomyopathy. EMBO Rep. 2024;25:5507. doi:10.1038/s44319-024-00271-x
- Li ZH, Song WQ, Qiu CS, Li HM, Tang XL, et al. Fish oil supplementation, genetic susceptibility and risk of new-onset hypertension. Prev Med. 2024;189:108152. doi:10.1016/j.ypmed.2024.108152
- Hamaya R, Cook NR, Sesso HD, Buring JE, Manson JE. A Bayesian Analysis of the VITAL Trial: Effects of Omega-3 Fatty Acid Supplementation on Cardiovascular Events. Am J Clin Nutr. 2025. doi:10.1016/j.ajcnut.2025.02.028
- Liboriussen C, Nygaard L, Jensen JD, Schmidt EB, Glerup RI, et al. Low Plasma Marine N-3 Polyunsaturated Fatty Acids are Associated with Increased Risk of Cardiovascular Events in Patients Treated with Maintenance Hemodialysis. J Ren Nutr. 2025. doi:10.1053/j.jrn.2025.02.001
- Yunoki K, Matsumi H, Miyoshi T, Kubo M, Hata Y, et al. Clinical Significance of Serum Omega-3 Fatty Acids on Endothelial Function in Patients with Coronary Artery Disease Under Statin Therapy. J Cardiovasc Dev Dis. 2025;12. doi:10.3390/jcdd12020060
- Patil T, Gregory M, Savona N, Jarmukli N, Leonard CE. Evaluating the Real-World Safety of Icosapent Ethyl Versus Omega-3 Polyunsaturated Fatty Acid in Nationwide US Veterans Cohort: Examining Atrial Fibrillation and Bleeding Endpoints. Clin Drug Investig. 2025;45:69. doi:10.1007/s40261-024-01417-4
- Kim JY, Kong SYJ, Jung E, Cho YS. Omega-3 Fatty Acids as Potential Predictors of Sudden Cardiac Death and Cardiovascular Mortality: A Systematic Review and Meta-Analysis. J Clin Med. 2024;14. doi:10.3390/jcm14010026
- Lamon-Fava S. Associations between omega-3 fatty acid-derived lipid mediators and markers of inflammation in older subjects with low-grade chronic inflammation. Prostaglandins Other Lipid Mediat. 2025;176:106948. doi:10.1016/j.prostaglandins.2025.106948
- Fukuda T, Nakajima T, Hasegawa T, Amano H, Arikawa T, et al. Relationship Between Serum ω-3 Polyunsaturated Fatty Acid Concentration and Fatty Acid Fraction of Epicardial Adipose Tissue in Patients With Cardiovascular Disease. Cureus. 2024;16:e73417. doi:10.7759/cureus.73417
- O'Keefe EL, O'Keefe JH, Abuissa H, Metzinger M, Murray E, et al. Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword. Prog Cardiovasc Dis. 2024. doi:10.1016/j.pcad.2024.11.003
- Choi JH, Park SE, Kim S. Antarctic Krill Oil Supplementation Attenuates Hypercholesterolemia, Fatty Liver, and Oxidative Stress in Diet-Induced Obese Mice. Nutrients. 2024;16. doi:10.3390/nu16213614
- So J, Yao JH, Magadmi R, Matthan NR, Lamon-Fava S. Sex differences in lipid mediators derived from omega-3 fatty acids in older individuals with low-grade chronic inflammation. Prostaglandins Leukot Essent Fatty Acids. 2024;203:102655. doi:10.1016/j.plefa.2024.102655
- Choi GY, Calder PC. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials. Front Nutr. 2024;11:1423228. doi:10.3389/fnut.2024.1423228
- Follonier C, Rabassa G, Branca M, Carballo D, Koskinas K, et al. Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes. Atheroscler Plus. 2024;58:1. doi:10.1016/j.athplu.2024.09.002
- Koutsaliaris IK, Pantazi D, Tsouka AN, Argyropoulou O, Tellis CC, et al. Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro. Int J Mol Sci. 2024;25. doi:10.3390/ijms251810136
- Ren Y, Chen B, Zhang H, Xu S. A cohort study reveals shared and distinct serum metabolic biomarkers for major adverse cardiovascular events in middle-aged and older adults. Geroscience. 2025. doi:10.1007/s11357-025-01544-6
- Arghavani H, Bilodeau JF, Rudkowska I. Association Between Circulating Fatty Acids and Blood Pressure: A Review. Curr Nutr Rep. 2025;14:15. doi:10.1007/s13668-024-00602-3
- Li J, Guo J, Yuen M, Yuen H, Peng Q. The comparative effects of ω-7 fatty acid-rich sea buckthorn oil and ω-3 fatty acid-rich DHA algal oil on improving high-fat diet-induced hyperlipidemia. Food Funct. 2025;16:1241. doi:10.1039/d4fo04961f
- Berkowitz L, Echeverría G, Salazar C, Faúndez C, Coe CL, et al. Lipidomic Signature of Healthy Diet Adherence and Its Association with Cardiometabolic Risk in American Adults. Nutrients. 2024;16. doi:10.3390/nu16233995
- Shi F, Chowdhury R, Sofianopoulou E, Koulman A, Sun L, et al. Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis. Eur J Prev Cardiol. 2025;32:233. doi:10.1093/eurjpc/zwae315
